EGFR-L858R, a constitutively active mutant that was reported in NSCLC patients, also phosphorylated both wt and C-lobe mutant ERBB3 in a ligand-independent manner (Figure 2E). The gene discussed is ERBB3; the disease is non-small cell lung carcinoma.